Clinical trial

Prn Budesonide/Formoterol Versus Regular Budesonide/Formoterol Plus Prn Terbutaline in Mild-Moderate Asthma

NCT00849095

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention budesonide/formoterol combination (PRN) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention budesonide/formoterol combination Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention placebo Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record terbutaline Normalized identity: terbutalineView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Prn Budesonide/Formoterol Versus Regular Budesonide/Formoterol Plus Prn Terbutaline in Mild-Moderate Asthma

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-04-01

PhasePHASE3

Conditions

Asthmaverified · MONDO: asthma

Interventions

budesonide/formoterol combination (PRN)DRUG

budesonide/formoterol combinationDRUG

placeboDRUG

terbutalineDRUG · verified · RxNorm: terbutaline

Sponsors & collaborators

Università degli Studi di Ferraralead sponsor

Mapped research locations

RomaItaly1 NaplesItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00849095 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.